SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-20-268654
Filing Date
2020-10-13
Accepted
2020-10-13 17:31:01
Documents
1
Effectiveness Date
2020-10-13

Document Format Files

Seq Description Document Type Size
1 S-8 POS d807496ds8pos.htm S-8 POS 24445
  Complete submission text file 0001193125-20-268654.txt   25582
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-223102 | Film No.: 201237492
SIC: 2834 Pharmaceutical Preparations